OssDsign AB
The answer first
Does OssDsign beat the market?
No, OssDsign has not beaten the market over the last year.
The ranking · Quality, value and trend combined
Better than 25% of Nordic stocks
- Quality73
- Value33
- Trend10
No. 118 of 195 in healthcare
Max for seven days
Follow OssDsign with AuroraAurora lets you know at the next report. No card.
Both with dividends. Figures as of 18 November 2026. General analysis, not personal advice.
Follow your thesis
Ask Aurora about OssDsign
Your first answer is free, no account needed.
Do you own OssDsign, or are you thinking about it?
See it next to the rest of your portfolio, or build your first one with OssDsign and a few more. Free, no card.
Super Stock+44.6%In short
- OssDsign has fallen 70.8% over the past year, including dividends.
- Overall, OssDsign ranks better than 25% of Nordic stocks on quality, value and trend.
- The largest fall over the past three years was 80.7%. The price is 83.1% below its peak now.
What do analysts think of OssDsign?
Quality, value and trend
Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.
Quality, value and trend together. Better than 25% of Nordic stocks.
No. 118 of 195 in healthcare
High A solid company: it earns well on its money and has healthy finances.
No. 76 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50
- Debt to equityBorrowings divided by equity0.00
- Asset turnoverSales divided by everything the company owns0.43
- Return on equityProfit divided by equity−18.0%
- Cash conversionOperating cash flow divided by profit–
The ranking is built on equity ratio, ROA and how steadily profit grows.
Low High price: buyers pay a lot today, often because they expect growth.
No. 67 of 197 in healthcareTypical in healthcare: 20Typical in the Nordics: 50
- P/BPrice divided by equity1.2
- P/SPrice divided by sales2.2
- P/EPrice divided by earningsnegative earnings
- P/CFPrice divided by operating cash flownegative earnings
The ranking is built on P/E, P/B and P/S.
Low Headwind in the share price: it has done worse than most over the last year.
No. 153 of 198 in healthcareTypical in healthcare: 34Typical in the Nordics: 50
- 3 months−20.5%
- 6 months−22.4%
- 9 months−50.3%
- 12 months−70.8%
The ranking is built on 3, 6 and 12–1 months.
Return and risk
Return with dividends reinvested.
The funds that own OssDsign
One fund we follow owns OssDsign. The share is how much of the fund the stock makes up.
- Sweden1
From the funds' latest known holdings.
About OssDsign
OssDsign AB is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 38 employees.
OssDsign AB (publ) designs, manufactures, and sells implants and material technology for bone regeneration in the United States. The company offers OssDsign Catalyst, a nanosynthetic bone graft engages in dual bone formation pathways through fusion mass. OssDsign AB (publ) was founded in 2011 and is headquartered in Uppsala, Sweden.


See the full analysis of OssDsign.
The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.
Free forever · No card